Knowles Sets 2026-2029 Targets: 8-10% Revenue CAGR, 10-14% EBITDA CAGR
KN sits 59% above its 52-week low of $20.57.
Summary
At the Baird conference, Knowles laid out 2026-2029 targets: 8-10% revenue CAGR, 10-14% adjusted EBITDA CAGR, and 16-20% operating cash flow as a share of revenue, backed by a $340M+ M&A war chest and a 2.75x leverage cap.
Key Events · Earnings and Guidance · KN
-
Multi-Year Targets Introduced
Knowles guided to 8-10% revenue CAGR and 10-14% adjusted EBITDA CAGR for 2026-2029, with cash from operations at 16-20% of revenue.
-
Growth Split by Segment
The revenue build assumes 6-8% growth in Precision Devices, 2-4% in MedTech & Specialty Audio, and 4% from acquisitions.
-
Capital Allocation Framework
Management cited $340M+ of existing liquidity for acquisitions, a 2.75x net leverage limit, and $271M already executed on the $400M buyback through Q4 2025.
-
Targets Not GAAP-Reconciled
The forward adjusted EBITDA CAGR is not reconciled to the comparable GAAP measure because the required information is unavailable without unreasonable effort.
Analysis · KN · Manufacturing
Why it matters: Knowles used its Baird Global Industrial Conference presentation to put hard numbers on the medium-term outlook for the first time. The targets call for 8-10% annual revenue growth through 2029 and 10-14% adjusted EBITDA growth, with cash from operations at 16-20% of revenue. Roughly half the top-line target depends on dealmaking, since the revenue build leans on 6-8% growth in Precision Devices and 2-4% in MedTech & Specialty Audio, plus 4% from acquisitions. Management also restated the capital allocation rules: $340M+ of liquidity for M&A, a 2.75x net leverage ceiling, and $271M already spent on the $400M buyback through Q4 2025. These targets are aspirational and not reconciled to GAAP, but they give investors a concrete bar to measure the post-transformation portfolio against, which is why this is more than a routine conference slide deck.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KN was trading at $32.74 on NYSE in the Manufacturing sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $20.57 to $42.93. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.